Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001213900-25-042042·NKGen Biotech, Inc.
Schedule 13D ownership disclosure
NKGEN BIOTECH INC
Common Stock · CUSIP: 65488A101
Event date: 2025-05-05
- Filing-level shares
- 63,738,042.00
- Percent of class
- 54.3%
- Paul Y. SongReported CIK 0001991119
Shares: 63,738,042.00 · Class: 54.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-042042
- Form type
- SCHEDULE 13D
- Filer
- NKGen Biotech, Inc.
- CIK
- CIK 1845459
- Filed
- May 12, 2025
- Reporting period
- May 05, 2025
- Description
- Schedule 13D beneficial ownership